High Risk Neuroblastoma
Also known as: High-Risk Neuroblastoma
Drug | Drug Name | Drug Description |
---|---|---|
DB09077 | Dinutuximab | An immunotherapeutic agent used in combination with other immunomodulating agents to treat high-risk neuroblastoma in pediatric patients who achieve at least a partial response to prior first-line multiagent, multimodality therapy. |
DB06243 | Eflornithine | An ornithine decarboxylase inhibitor used to prevent relapse of high-risk neuroblastoma in pediatric and adult patients |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB09077 | Dinutuximab | GD2 disialoganglioside | target |
DB06243 | Eflornithine | Ornithine decarboxylase | target |